治疗 2型糖尿病的新药阿卡波糖在控制餐后血糖、空腹血糖及糖化血红蛋白值等方面作用显著 ,疗效确切 ,且无全身副作用和低血糖反应 ,不增加体重 ,禁忌症少 ,药物相互作用少 ,已被越来越多的医生认同为临床一线用药[1 ] 。但该药在服用过程中 ,相当一部份产生胃肠道副作用 ,其中 The novel drug acarbose for the treatment of type 2 diabetes has a significant effect in controlling postprandial blood glucose, fasting blood glucose and glycated hemoglobin values, has definite curative effect, has no systemic side effects and hypoglycemia reactions, does not increase body weight, has few contraindications, and has drug interactions. Less has been recognized by more and more doctors as a clinical first-line medication [1]. However, during the course of taking the drug, a considerable part of it produces gastrointestinal side effects.